This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

13 Mar 2012

KingMed Inks Pact with Qiagen for HPV Assay Services

KingMed Diagnostics is to operate as a centralized laboratory offering Qiagen's digene HPV assay. The collaboration is expected to expand access to the test in second-tier and third-tier cities in China.

China’s independent laboratory network KingMed Diagnostics has signed an agreement with Qiagen to operate as a centralized laboratory offering the latter’s digene HPV assay. 


KingMed will act to process and analyze samples sent from hospitals that don’t directly provide the digene assay themselves, to help expand access to the test across the country.


The digene HPV test was first registered in China in 2000 and is available in a number of the country‘s largest hospitals and private laboratories.


Qiagen says the deal with KingMed represents a milestone for its molecular diagnostics franchise in China, and its drive to expand in emerging markets. T

Related News